The initiation of receptor-mediated small artery contraction is dependent on inositol 1,4,5-trisphosphatestimulated release of stored calcium. The role of the other product of inositol lipid hydrolysis, 1,2-diacylglycerol, in maintaining contraction remains controversial. Therefore, we have determined the contractile response of rat subcutaneous small arteries (<300 ,m i.d.), when mounted as ring preparations in a myograph, to noradrenaline, angiotensin II, KCl-induced membrane depolarization, and a cell-permeable diglyceride, dioctanoylglycerol. In parallel experiments, the conversion of this diglyceride to dioctanoylphosphatidate was studied in 32P-labeled vessels. Dioctanoylglycerol produced a slow-onset sustained contraction that was dependent on extracellular calcium. This was accompanied by the generation of the lipid dioctanoylphosphatidate. Noradrenaline and KCI induced rapid-onset sustained contractions and increased the production of dioctanoylphosphatidate (75% and 91%, respectively). In addition, dioctanoylglycerol levels were reduced (41%) after noradrenaline stimulation, suggesting activation of diacylglycerol kinase. In contrast, the contractile response to angiotensin II was transient, and this agonist did not significantly affect the conversion of dioctanoylglycerol to phosphatidate. Noradrenaline markedly increased (fourfold) the formation of endogenous phosphatidate, whereas endogenous 1,2-diacylglycerol was increased (47%) with angiotensin II. These results demonstrate that phosphatidate formation is regulated by vasoconstrictor hormones during receptor-mediated contraction, independent of diglyceride mass. Modulation of the levels of lipid second messengers downstream from phospholipid hydrolysis may represent a mechanism by which agonists that act through the same signaling system produce different contractile responses. (Circulation Research 1993;72:1163-1171 KEY WORDS * diacylglycerol * contractile response * noradrenaline * angiotensin II diacylglycerol kinase T he binding to their receptors of vasoconstrictor hormones such as noradrenaline (NA) and angiotensin II (Ang II) links these agonists to a common signaling system and activates phospholipase C (PLC), which hydrolyzes the membrane lipid phosphatidylinositol 4,5-bisphosphate. This results in the production of two second messengers, inositol 1,4,5-trisphosphate (Ins 1,4,5-P3) and 1,2-diacy1glycerol (1,2-DAG).' There is good evidence to suggest that Ins 1,4,5-P3 can initiate contraction by stimulating the release of calcium from intracellular stores.2 However, the sequence of events that sustains contraction in vascular smooth muscle is still unclear. 1,2-DAG is known to serve as a second messenger in protein kinase C (PKC)-mediated signal transduction,3 but whether PKC plays a role in vascular smooth muscle contraction is not established. It has been proposed that PKC enhances contraction by increasing calcium influx and the phosphorylation of myosin light chain kinase45 or, conversely,
T he binding to their receptors of vasoconstrictor hormones such as noradrenaline (NA) and angiotensin II (Ang II) links these agonists to a common signaling system and activates phospholipase C (PLC), which hydrolyzes the membrane lipid phosphatidylinositol 4,5-bisphosphate. This results in the production of two second messengers, inositol 1,4,5-trisphosphate (Ins 1,4,5-P3) and 1,2-diacy1glycerol (1,2-DAG).' There is good evidence to suggest that Ins 1,4,5-P3 can initiate contraction by stimulating the release of calcium from intracellular stores. 2 However, the sequence of events that sustains contraction in vascular smooth muscle is still unclear. 1,2-DAG is known to serve as a second messenger in protein kinase C (PKC)-mediated signal transduction,3 but whether PKC plays a role in vascular smooth muscle contraction is not established. It has been proposed that PKC enhances contraction by increasing calcium influx and the phosphorylation of myosin light chain kinase45 or, conversely, that it reduces contraction by negative feedback on phospholipid breakdown. [6] [7] [8] There is now a growing body of evidence to support an alternative mechanism for sustained smooth muscle contraction via calcium sensitization. It has been shown that phosphatase activity is decreased during tonic contraction by a guanine nucleotide-binding protein (G protein)-mediated effect, leading to prolonged phosphorylation of the 20-kd light chains of myosin and increased calcium sensitivity.910 As yet, the second messengers involved in this sensitization process are unknown, although recent studies have implicated arachidonic acid." It should be noted that 1,2-DAG is an important source of 1) arachidonic acid, which is an essential precursor of prostaglandins and eicosanoids, and 2) phosphatidic acid (PA). The functional role of PA in signal transduction is uncertain. However, this lipid has been shown to increase calcium influx and efflux,'2-14 to stimulate PLC hydrolysis of phospholipids,1'516 to cause contraction of vascular smooth muscle cells,17 to be involved in carbachol-induced contraction of guinea pig taenia coli,18 and to induce cell proliferation,15 possibly by its ability to interact with GTPase-activating protein. 19 Recently, some of these observations have been ascribed to contamination of PA with lyso-PA,20 although this is not resolved fully. 21 Therefore, the mechanisms that regu-late the levels of PA in contractile tissues are of considerable interest.
Previously, we have reported that the vasoconstrictor hormones NA and Ang II have different effects on the accumulation of 1,2-DAG and PA during the onset of contraction in rat small arteries. 22 This suggested that differential metabolism of 1,2-DAG might be important in discriminating the effects of these pressor agents that act on distinct receptors but are coupled to the same transmembrane signaling system. In the present study, we have extended these findings by examining the role of diacylglycerol (DAG) kinases in the production of PA in intact vessels, using the cell-permeable shortchain diglyceride dioctanoylglycerol (diC8), and by measuring the production of the novel lipid dioctanoylphosphatidic acid (PAs). We have studied both basal diC8 metabolism and the effects of the vasoconstrictor hormones NA and Ang II. Concomitant functional studies show that, in this arterial preparation, NA produced a sustained contraction but that the Ang II response was transient. From our results, we propose that vasoconstrictor hormones may influence the production of PA through a receptor-mediated effect on DAG kinase(s). The differences in the metabolism of 1,2-DAG that result may underlie the distinct contractile profiles observed with these agonists.
Materials and Methods

Animals
Adult female Wistar and Sprague-Dawley rats (approximately 200 g body weight) were used for all the experiments described.
Tissue Preparation
The animals were killed by stunning followed by cervical dislocation. Two subcutaneous small arteries (<300 ,um i.d.) supplied by the axillary artery were dissected from each rat and cleaned of adherent fat and connective tissue. In experiments determining the levels of 1,2-DAG, the tissues were transferred to an Eppendorf tube containing 100 ,gl culture medium (M199) composed of (mM) NaCI 128, KCl 5.4 
Determination of Contractile Response
After dissection, segments of small arteries were mounted as ring preparations in a myograph.27 After mounting, the segments were maintained in physiological salt solution (PSS) containing (mM) NaCl 119, KCl 4.7, MgSO4-7H20 1.17, KH2PO4 1.18, NaHCO3 2.5, CaCl2* 2H20 2.5, glucose 5.5, and EDTA 0.026, pregassed with 5% CO2 in 02 at 37°C for 1 hour, and then set to an internal circumference at which they were held just under tension. The resting tension-internal circumference relation was then determined, and the vessels were set to a normalized internal circumference, which was 90% of that which the vessel would have when relaxed and under a transmural pressure of 100 mm Hg. 27 The vessels were then activated with NA (10 ,M) in K+-PSS (equimolar substitution of KCI for NaCl) twice, followed by NA in PSS, K+-PSS, and finally NA in K+-PSS. Each solution was applied for 2 minutes before washing out with PSS. Vessels were allowed to relax between these activations. The vessels were then equilibrated in HEPES buffer (composition as for M199) before stimulation with the following agonists: 15 ,gM NA, 100 nM Ang II, 100 ,uM diC8, and 125 mM KCl±+1 ,uM prazosin. The agonists were applied in HEPES buffer for 5 minutes, and the responses were recorded with a chart recorder (Grass Instrument Co., Quincy, Mass.). A minimum of 15 minutes was allowed for a recovery period between each agent. In the experiments using prazosin, the vessels were preincu- Dimethyl esters of standard [2P1PA8 and vessel extract [32P]PA8 were prepared with an ethereal solution of diazomethane; the resultant esters were applied to a 3-,um C8 microsorb column and eluted with a nonlinear preprogrammed gradient of acetonitrile/methanol/10% AgNO3 as previously described.22 Column fractions were collected, and the radioactive peaks were determined by scintillation counting. The solid line represents standard PA8, and the dashed line represents vessel extract PA8. over a period of 10 minutes in the presence and absence of calcium in the external medium. produced by in situ phosphorylation is the same as that produced by in vitro phosphorylation of diC8, we used HPLC to demonstrate that both forms coeluted exactly ( Figure 1 ). Incubation of small arteries with 100 ,M diC8 resulted in the rapid appearance of PA8, which was maximal at 5 minutes and remained stable up to 15 minutes, after which there was a slight decline to 30 minutes ( Figure 2 ). In a further set of experiments, the vessels were incubated with 100 4M diC8 for 10 minutes and then transferred to medium without diC8 to follow the metabolism of this lipid. The tissue levels of diC8 fell rapidly and were virtually undetectable after 15 minutes. However, the diC8 did not accumulate as PA8, because levels of this lipid fell in parallel with substrate ( Figure 3) . Incubation of the arteries with increasing concentrations of diC8 (from 10 to 100 ,uM) resulted in dose-related increases in extracted diC8 and PA8 (Table  1 ). The increase in the diglyceride levels (sevenfold from 10 to 100 ,uM) was greater than the increase in the corresponding phosphatidate (twofold from 10 to 100 gm).
Materials
To study the effects of agonists on the conversion of Small arteries were incubated with varying concentrations of diC8, and then the lipids were extracted. Mass levels of 1,2-DAG and diC8 and the incorporation of [`P]P04 into PA and PA8 were determined as described in "Materials and Methods."
Effects of NA and Ang II
The doses of agonist used are those that elicit a maximal contractile response in these vessels. A time point of 20 seconds of stimulation was chosen because this is during the initial phase of contraction and is also the time when the greatest differences in lipid profiles have been observed.22 Figure 4 illustrates the mechanical response of these small arteries to the agonists. Both agents induced a contraction. However, the response was of smaller magnitude and not maintained with Ang II. These contractile profiles are in agreement with other functional studies in small arteries. 
Effects of Membrane Depolarization With Potassium
It has been shown that raised levels of intracellular calcium will inhibit PA CTP transferase and thus slow the metabolism of PA through the phosphoinositol cycle.32 Therefore, we determined the effects of potassium depolarization (125 mM KCl), a maneuver that raises intracellular calcium levels.33 This level of KCl (125 mM) induced a rapid and sustained contraction in small arteries, similar to the response seen with NA ( Figure 4) , and an increase in the production of [32P]PA8 (+91%, p<0.01) (Figure 7) . However, in the presence of the a,-adrenoreceptor antagonist prazosin (1 ,M), the effect on [`2P]PA8 was abolished ( Figure 7 ). This indicated that the effects on PA levels with potassium alone were due to the action of catecholamines released by depolarization of nerve terminals in the vessel wall. In the presence of prazosin (1 ,uM), the initial phase of the contractile response was also slightly reduced, approximately 50% (Figure 4) , showing a contribution of catecholamines to the contraction.
Effects of diC8
Incubation of small arteries with 100 ,M diC8 for 10 minutes resulted in the slow development of tension ( Figure 4) . Replacement of the external medium with "nominally free calcium" solution abolished the response, implying that calcium influx was involved in the contraction. At none of the dose levels of diC8 was there an effect on basal levels of endogenous 1,2-DAG or
[32P]PA (Table 1 effects on the production of this lipid. In the absence of diCQ, neither of the agonists had any effect on the levels of total endogenous 1,2-DAG. Again, this was in agreement with our previous studies. 22 However, preincubation with 100 ,uM diC8 resulted in a reduction of endogenous 1,2-DAG after stimulation with NA (15 ,uM) (-37%, p<0.001) (Figure 8 ). In contrast, after preincubation with 100 ,M diC8, stimulation with Ang II (100 nM) resulted in an increase in endogenous 1,2-DAG (+47%,p<0.05) (Figure 8 In agreement with studies in other cell types,2834,35 diC8 was rapidly phosphorylated to produce PA8, the levels of which remained stable for up to 15 minutes. The PA8 was efficiently metabolized, as shown by its complete disappearance 15 minutes after the removal of substrate from the incubation medium. The uptake of diC8 by the arteries was dose-related; there was a sevenfold increase in vessel diC8 for a 10-fold increase in external concentration. In contrast, PA8 levels were increased only twofold, further suggesting active metabolism of this novel lipid. We were unable to determine the pathway of PA8 metabolism in our tissue because of the relatively low degree of 32p radiolabeling of this lipid. However, in two previous studies, [3H]diC8 was shown to accumulate in other phospholipids2835 with a slower time course than the appearance of [SHIPAs.28 Bishop and BelV28 further separated this phospholipid fraction and demonstrated a significant incorporation of radiolabel into phosphatidylinositol with initially far less radioactivity in phosphatidylcholine. Similarly, Severson and Hee-Cheong35 observed only slight incorporation of [3H]diC8 into phosphatidylcholine in rabbit aortic smooth muscle cells. Therefore, it is most likely that the PA8 in our preparation was incorporated into phosphatidylinositol, presumably by the enzyme CTP-PA cytidyl transferase. Obviously, this is an active metabolic pathway in small arteries, implying that the levels of PA are tightly controlled in nonstimulated tissue. These data also show that diC8 is a substrate for DAG kinase in such small vessels.
KCI did not alter either diC8 or endogenous 1,2-DAG metabolism, implying that elevation of intracellular calcium and membrane depolarization did not affect induced a variable and nonsustained contraction. Similar responses to Ang II have been reported by other workers in different vascular beds. 30 The lack of a sustained contraction does not appear to be explained by a termination of the Ang II response, e.g., receptor uncoupling, internalization of receptors, or Ang II degradation, because we have shown the sustained production of 1,2-DAG for time periods up to 5 minutes.22 Therefore, it would appear that the generation of inositol phosphates and arachidonate containing 1,2-DAG is not sufficient to ensure a maintained contraction in small arteries. The stimulated production of other vasoactive substances such as PA in the case of NA may be necessary to sustain contraction. Whether PA modulates tonic contraction through direct mechanisms or indirectly through an effect on calcium levels remains to be investigated. Also, it should be noted that incubation of resistance arteries with 100 gM diCs resulted in the slow development of tension over a 10-minute period. This response was dependent on extracellular calcium and similar to that seen with phorbol esters in small arteries,41 suggesting that activation of PKC may have occurred. However, it is also possible that the PA8 formed was involved in the contraction; certainly the results with Ang II suggest that elevation of 1,2-DAG levels alone do not necessarily result in sustained contraction. There was no alteration in basal levels of endogenous 1,2-DAG and
[32P]PA during incubation with diC8. Therefore, increased cellular DAG and, presumably, activation of PKC did not affect basal levels of these lipids, indicating In summary, we have demonstrated differential regulation of the metabolism of diglycerides during contraction induced by two vasoactive agonists. It is possible that this is one way by which there is cell recognition of a particular ligand when the inositol phospholipid signaling system used is common to many stimuli. In addition, the route of production of metabolites and their identity may be pertinent to the rate of contraction observed in vascular smooth muscle and the degree to which it can be sustained.
